Van Thanh Le Thai, Minh Phuong Nguyen, Thuy Phuong Tran Thi, Gandolfi Marco, Satolli Francesca, Feliciani Claudio, Tirant Michael, Vojvodic Aleksandra, Lotti Torello
Department of Dermatology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Department of Plastic and Cosmetic Surgery, University Medical Center, Ho Chi Minh City, Vietnam.
Open Access Maced J Med Sci. 2019 Jan 20;7(2):279-282. doi: 10.3889/oamjms.2019.094. eCollection 2019 Jan 30.
Oral isotretinoin is an effective therapy for acne. However, isotretinoin can induce hyperhomocysteinemia and decreased serum folic acid level, which may be a risk for cardiovascular disease and thrombosis, as well as psychoses. Besides, many recent types of research emphasise the safety and effects of the low dose isotretinoin therapy.
The aim of our study was to evaluate the effect of the low-dose isotretinoin on the plasma homocysteine and serum folic acid level in the Vietnamese population.
We conducted a longitudinal study to evaluate the effectiveness of the low-dose therapy on the plasma homocysteine and serum folic acid level of 52 acne patients after 6-8-week treatment at University Medical Center Ho Chi Minh City, Viet Nam. Patients had moderate-severe acne with the prolonged course, and most of them had a scar.
With a low dose of oral isotretinoin (0.37 ± 0.11 mg/kg/day), after 6-8-week treatment, patients dropped the severity of disease, increased the plasma homocysteine level and decreased the serum folic acid level with significant differences in comparison to those before treatment. However, these changes do not exceed the normal range.
In overall, low dose isotretinoin treatment had effectiveness in decrease the severity of disease and no increasing the plasma homocysteine level as well as the serum folic acid level.
口服异维A酸是治疗痤疮的有效方法。然而,异维A酸可诱发高同型半胱氨酸血症并降低血清叶酸水平,这可能是心血管疾病、血栓形成以及精神病的一个风险因素。此外,最近许多研究都强调了低剂量异维A酸治疗的安全性和效果。
我们研究的目的是评估低剂量异维A酸对越南人群血浆同型半胱氨酸和血清叶酸水平的影响。
我们进行了一项纵向研究,以评估在越南胡志明市大学医学中心对52例痤疮患者进行6 - 8周治疗后,低剂量治疗对血浆同型半胱氨酸和血清叶酸水平的有效性。患者患有中度至重度痤疮且病程较长,并且大多数人有瘢痕。
口服低剂量异维A酸(0.37±0.11毫克/千克/天),经过6 - 8周治疗后,患者的疾病严重程度降低,血浆同型半胱氨酸水平升高,血清叶酸水平降低,与治疗前相比有显著差异。然而,这些变化未超出正常范围。
总体而言,低剂量异维A酸治疗在降低疾病严重程度方面有效,且不会增加血浆同型半胱氨酸水平和血清叶酸水平。